40 related articles for article (PubMed ID: 30332788)
1. Structural and Biological Investigations for a Series of N-5 Substituted Pyrrolo[3,2-
Cawrse BM; Robinson NM; Lee NC; Wilson GM; Seley-Radtke KL
Molecules; 2019 Jul; 24(14):. PubMed ID: 31340431
[TBL] [Abstract][Full Text] [Related]
2. Nucleoside Analogs That Inhibit SARS-CoV-2 Replication by Blocking Interaction of Virus Polymerase with RNA.
Matyugina E; Petushkov I; Surzhikov S; Kezin V; Maslova A; Ivanova O; Smirnova O; Kirillov I; Fedyakina I; Kulbachinskiy A; Kochetkov S; Khandazhinskaya A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834771
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside Analogs and Perylene Derivatives Modulate Phase Separation of SARS-CoV-2 N Protein and Genomic RNA In Vitro.
Svetlova J; Knizhnik E; Manuvera V; Severov V; Shirokov D; Grafskaia E; Bobrovsky P; Matyugina E; Khandazhinskaya A; Kozlovskaya L; Miropolskaya N; Aralov A; Khodarovich Y; Tsvetkov V; Kochetkov S; Lazarev V; Varizhuk A
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499608
[TBL] [Abstract][Full Text] [Related]
4. Discovery, Design, Synthesis, and Application of Nucleoside/Nucleotides.
Seley-Radtke K
Molecules; 2020 Mar; 25(7):. PubMed ID: 32230805
[TBL] [Abstract][Full Text] [Related]
5. An overview on synthetic and pharmaceutical prospective of pyrido[2,3-d]pyrimidines scaffold.
Yadav P; Shah K
Chem Biol Drug Des; 2021 Mar; 97(3):633-648. PubMed ID: 32946161
[TBL] [Abstract][Full Text] [Related]
6. FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application.
Wang S; Yuan XH; Wang SQ; Zhao W; Chen XB; Yu B
Eur J Med Chem; 2021 Mar; 214():113218. PubMed ID: 33540357
[TBL] [Abstract][Full Text] [Related]
7. Novel 5'-Norcarbocyclic Derivatives of Bicyclic Pyrrolo- and Furano[2,3-d]Pyrimidine Nucleosides.
Klimenko AA; Matyugina ES; Logashenko EB; Solyev PN; Zenkova MA; Kochetkov SN; Khandazhinskaya AL
Molecules; 2018 Oct; 23(10):. PubMed ID: 30332788
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line.
Jung MH; Kim H; Choi WK; El-Gamal MI; Park JH; Yoo KH; Sim TB; Lee SH; Baek D; Hah JM; Cho JH; Oh CH
Bioorg Med Chem Lett; 2009 Dec; 19(23):6538-43. PubMed ID: 19857963
[TBL] [Abstract][Full Text] [Related]
9. Novel Bis- and Mono-Pyrrolo[2,3-
Bistrović Popov A; Vianelo R; Grbčić P; Sedić M; Pavelić SK; Pavelić K; Raić-Malić S
Molecules; 2021 Jun; 26(11):. PubMed ID: 34206076
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel 6-substituted pyrrolo [3,2-d] pyrimidine analogues as antifolate antitumor agents.
Tian C; Wang M; Han Z; Fang F; Zhang Z; Wang X; Liu J
Eur J Med Chem; 2017 Sep; 138():630-643. PubMed ID: 28711701
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety.
Geng PF; Liu XQ; Zhao TQ; Wang CC; Li ZH; Zhang J; Wei HM; Hu B; Ma LY; Liu HM
Eur J Med Chem; 2018 Feb; 146():147-156. PubMed ID: 29407946
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
13. Searching for anti-glioma activity. Ribonucleoside analogues with modifications in nucleobase and sugar moieties.
Framski G; Wawrzyniak D; Jahnz-Wechmann Z; Szymanska-Michalak A; Kraszewski A; Barciszewski J; Boryski J; Stawinski J
Acta Biochim Pol; 2016; 63(4):765-771. PubMed ID: 27830840
[TBL] [Abstract][Full Text] [Related]
14. Bioactive fused heterocycles: Nucleoside analogs with an additional ring.
Jahnz-Wechmann Z; Framski G; Januszczyk P; Boryski J
Eur J Med Chem; 2015 Jun; 97():388-96. PubMed ID: 25576500
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of furopyrimidine N,O-nucleosides.
Romeo R; Giofrè SV; Garozzo A; Bisignano B; Corsaro A; Chiacchio MA
Bioorg Med Chem; 2013 Sep; 21(18):5688-93. PubMed ID: 23932449
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
